Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission.

Authors :: Short NJ
Macaron W
Kadia T
Dinardo C
Issa GC
Daver N
Wang S
Jorgensen J
Nguyen D
Bidikian A
Patel KP
Loghavi S
Konopleva M
Yilmaz M
Jabbour E
Maiti A
Abbas HA
Shpall E
Popat U
Al-Atrash G
Pierce S
Kantarjian HM
Ravandi F
Source :: American journal of hematology [Am J Hematol] 2022 Nov; Vol. 97 (11), pp. E408-E411. Date of Electronic Publication: 2022 Sep 08.
Publication Year :: 2022
Abstract: Recurrence of MRD in AML is associated with imminent relapse unless intervened upon. Change in chemotherapy regimen and/or immediate transplant improve outcomes.<br /> (© 2022 Wiley Periodicals LLC.)

Subjects :: Humans
Neoplasm, Residual
Prognosis
Recurrence
Hematopoietic Stem Cell Transplantation
Leukemia, Myeloid, Acute drug therapy

Full Text Access

Tools